Skip to content

Clinical trials

Active, not recruiting Lymphoma, B-Cell, Marginal Zone trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Status: Active, not recruiting Country / region: Germany Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20182
20192
20201
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Christian Buske2
AbbVie1
BeOne Medicines1
Celgene1
Genmab1
Incyte Corporation1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone8
Lymphoma, Follicular5
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, B-Cell2
Lymphoma, Mantle-Cell2
Neoplasms2
Recurrence2
Hematologic Neoplasms1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Non-Hodgkin1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.